Advanced search
Instruments
Name | Stock exchange | Average volume | Price | Type | ||
---|---|---|---|---|---|---|
HAIG SECU1.33833 | 5483 | Hong Kong S.E. | - | - % | Bond | |
HAIG UT324 | 40703 | Hong Kong S.E. | - | - % | Bond | |
HAIG SECU2.12523 | 40273 | Hong Kong S.E. | - | - % | Bond | |
HAIG SECU4.523 | 5482 | Hong Kong S.E. | - | - % | Bond | |
HAIG UT4.2BD25 | 5215 | Hong Kong S.E. | - | - % | Bond | |
HAIG UT3.65BD27 | 84497 | Hong Kong S.E. | - | - % | Bond | |
HAIG FINA3.2GTD BD | 84429 | Hong Kong S.E. | - | - % | Bond | |
HAIG FINA3.3GTD BD | 84490 | Hong Kong S.E. | - | - % | Bond | |
HAIG SECUSUBS RTS2 | 2941 | Hong Kong S.E. | - | - HKD | Stock |
Companies (1)
Guangzhou Haige Communications Co., Ltd. specializes in the manufacture and marketing of navigation and communications equipment to the areas of government services, finance, transportation and defense. The group's products include mobile communication sy ...
Insiders
Presently, Haig B. Buchakjian occupies the position of Executive Vice President-Operations of Brixmor Property Group, Inc. Mr. Buchakjian previously occupied the position of SVP, VP-Construction & Project Manager at New Plan Excel Realty Trust, Inc. Mr. Buchakjian received an undergraduate degree from Rutgers State University of New Jersey and an MBA from The Trustees of Columbia University in The City of New York.
Haig P.
Bozigian is currently the Chief Development Officer at Neurocrine Biosciences, Inc. He started this position in 2006.
Prior to his current role, he worked as the Director of Pharmaceutical Development at ProCyte Corp.
and as the Associate Director of Pharmacokinetics at Sphinx Pharmaceuticals Corp.
Bozigian holds a doctorate degree from the University of Arizona, an undergraduate degree from the University of Massachusetts, and a graduate degree from the University of Nebraska Medical Center.
Tim Haig was a Managing Director for Germany, India, and Turkey at CPP Group Plc.
No results for this search
- Stock Market
- Advanced search
- Haig Buchakjian